MONTAVIT

Serial Number 98658785
690

Registration Progress

Application Filed
Jul 20, 2024
Under Examination
Apr 1, 2025
Approved for Publication
Feb 4, 2025
Published for Opposition
Feb 4, 2025
Registered

Trademark Image

MONTAVIT

Basic Information

Serial Number
98658785
Filing Date
July 20, 2024
Published for Opposition
February 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
690
Status Date
Oct 27, 2025
Application
Pending
Classes
005

Rights Holder

Pharmazeutische Fabrik MONTAVIT Gesellschaft m.b.H.

99
Address
Salzbergstraße 96
6067 Absam -
AT

Ownership History

Pharmazeutische Fabrik MONTAVIT Gesellschaft m.b.H.

Original Applicant
99
6067 Absam AT

Pharmazeutische Fabrik MONTAVIT Gesellschaft m.b.H.

Owner at Publication
99
6067 Absam AT

Legal Representation

Attorney
Rebeccah Gan

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

13 events
Date Code Type Description Documents
Oct 27, 2025 OTHE I CASE RETURNED TO EXAMINATION Loading...
Oct 27, 2025 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Oct 27, 2025 PCBG O PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Loading...
Oct 23, 2025 APET A ASSIGNED TO PETITION STAFF Loading...
Sep 23, 2025 TPAD I TEAS PETITION TO AMEND BASIS RECEIVED Loading...
Apr 1, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 4, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 29, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 13, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 8, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 21, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 21, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Allergy medications; Antiallergic medicines; Medicines for intestinal disorders; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations acting on the central nervous system; Pharmaceuticals, namely, anthelmintics and antihistamines; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for treating alimentary tract and canal diseases and illnesses; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; All-purpose disinfectants; Urinary tract disinfectants; Disinfectants for sanitary purposes; Dietetic foodstuffs in the nature of vitamin supplements, vitamins and vitamin preparations, mineral food supplements, mineral supplements, mineral nutritional supplements, vitamin and mineral preparations for medical use, dietary and nutritional supplements and nutraceuticals for use as a dietary supplement; Medicated supplements for foodstuffs for animals; Medicated supplements for foodstuffs for babies

Classification

International Classes
005